Fluorescence quantitative polymerase chain reaction (PCR) detection kit for hepatitis B virus (HBV)

A hepatitis B virus detection kit technology, applied in the field of molecular biology, can solve the problems of difficult standardization and direct quantification of detection conditions, and achieve the effect of increasing TM value, shortening length and high resolution

Inactive Publication Date: 2012-12-12
ANHUI DAJIAN MEDICAL TECH CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

nPCR is a qualitative detection method and cannot be directly quantified. Its products need to be qualitatively judged by gel electrophoresis; It can be judged by gel electrophoresis; the advantage of cPCR is that it can effectively control the difference in amplification efficiency between different reaction tubes, and the concentration of the target gene can be adapted to a large range, but this method requires gel electrophoresis, Southern blot and labeled isotope probes are used for quantitative analysis. Although the sensitivity is high, the detection conditions are not easy to standardize

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fluorescence quantitative polymerase chain reaction (PCR) detection kit for hepatitis B virus (HBV)
  • Fluorescence quantitative polymerase chain reaction (PCR) detection kit for hepatitis B virus (HBV)
  • Fluorescence quantitative polymerase chain reaction (PCR) detection kit for hepatitis B virus (HBV)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: the sensitivity of the kit of the present invention for standard samples

[0035] The detection concentration of the fluorescent quantitative PCR detection kit of the present invention is respectively 10 4 copies / µl, 10 5 copies / µl, 10 6 copies / µl, 10 7 copies / μl of HBV DNA standard. The standard product in this experiment is the plasmid DNA synthesized by Treasure Bioengineering (Dalian) Co., Ltd.

[0036] The kit of the present invention contains a specially designed fluorescent probe and a pair of primers that can specifically detect HBV DNA:

[0037] Forward primer (HBV-Forward Primer):

[0038] 5'-CCTATGGGAGTGGGCCTCA-3'

[0039] Reverse primer (HBV-Reverse Primer):

[0040] 5'-CATCCATATAACTGAAAGCCAAACAGT-3'

[0041] Fluorescent probe (HBV-Taqman-Probe):

[0042] 5'-FAM-CTAGTGCCATTTGTTC-MGB-3'

[0043] Then optimize the reaction system for FQ-PCR detection, the fluorescence quantitative reaction is carried out on the ABI7900 detector, the rea...

Embodiment 2

[0047] Example 2: Sensitivity of the kit of the present invention for clinical samples

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a fluorescence quantitative PCR detection kit for HBV. The kit comprises a PCR master mix, a fluorescence quantitative reaction solution and a positive control sample. The fluorescence quantitative reaction solution refers to a reaction system comprising a forward primer, a reverse primer and a locked nucleotide probe which are used for detecting HBV DNA, wherein the sequence of the forward primer is SEQ ID NO:1, the sequence of the reverse primer is SEQ ID NO:2, the sequence of the Taqman probe is SEQ ID NO:3, the 5'end of the probe is marked with FAM, the 3'end of the probe is marked with a minor groove binder (MGB), and the positive control sample A comprises DNA plasmid of HBV genome fragments. The detection kit is suitable for quantitative detection of HBV nucleic acid in various tissues, cells, blood and other body liquid.

Description

technical field [0001] The invention belongs to the field of molecular biology and relates to a fluorescent quantitative PCR kit for detecting hepatitis B virus nucleic acid, which is suitable for quantitative detection of hepatitis B virus nucleic acid in various tissues, cells, blood and other body fluids. Background technique [0002] Hepatitis B virus (HBV) infection not only causes acute and chronic viral hepatitis, but also is closely related to liver fibrosis and hepatocellular carcinoma. It is a public health problem that seriously endangers human health all over the world. About 2 billion people in the world have been proven to be infected with hepatitis B, and 350 million people are chronically infected. According to the report of the World Health Organization, among the top 10 causes of death in the world, hepatitis B ranks 9th. my country is a high-incidence area of ​​HBV infection in the world. About 130 million people in the country are HBV carriers, and there ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/68G01N21/64
Inventor 邵琦
Owner ANHUI DAJIAN MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products